Cargando…

Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG

Overtreatment is a major concern in men diagnosed with prostate cancer. The aim of this study was to evaluate the combined prognostic role of three frequent molecular alterations in prostate cancer, namely relative 8q gain, ERG overexpression, and loss of PTEN expression, in a series of 136 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Maria P., Barros-Silva, João D., Ersvær, Elin, Kildal, Wanja, Hveem, Tarjei Sveinsgjerd, Pradhan, Manohar, Vieira, Joana, Teixeira, Manuel R., Danielsen, Håvard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143339/ https://www.ncbi.nlm.nih.gov/pubmed/27916292 http://dx.doi.org/10.1016/j.tranon.2016.08.005

Ejemplares similares

Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
por: Ersvær, Elin, et al.
Publicado: (2019)

Entropy-Based Adaptive Nuclear Texture Features are Independent Prognostic Markers in a Total Population of Uterine Sarcomas
por: Nielsen, Birgitte, et al.
Publicado: (2015)

PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
por: Cyll, Karolina, et al.
Publicado: (2021)

Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017)

Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers
por: Nielsen, Birgitte, et al.
Publicado: (2018)

Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)

Prognostic Classification of Early Ovarian Cancer Based on very Low Dimensionality Adaptive Texture Feature Vectors from Cell Nuclei from Monolayers and Histological Sections
por: Nielsen, Birgitte, et al.
Publicado: (2001)

The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
por: Nielsen, Birgitte, et al.
Publicado: (2012)

Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort
por: Morais, C.E., et al.
Publicado: (2019)

Automated assessment of CD8(+) T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
por: Jiang, Dan, et al.
Publicado: (2021)

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
por: Rescigno, Pasquale, et al.
Publicado: (2018)

Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
por: Bhalla, Ritu, et al.
Publicado: (2013)

Chromatin organisation and cancer prognosis: a pan-cancer study
por: Kleppe, Andreas, et al.
Publicado: (2018)

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
por: Al Bashir, Samir, et al.
Publicado: (2014)

Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
por: Rye, Inga Hansine, et al.
Publicado: (2021)

hERG Gating Microdomains Defined by S6 Mutagenesis and Molecular Modeling
por: Wynia-Smith, Sarah L., et al.
Publicado: (2008)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
por: NOH, BYEONG-JOO, et al.
Publicado: (2016)

Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives
por: Voulgari, Olga, et al.
Publicado: (2023)

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2015)

Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
por: Ribeiro, Franclim R., et al.
Publicado: (2011)

Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2015)

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
por: Pradhan, Manohar, et al.
Publicado: (2012)

Correction: Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis
por: Lotfali, Ensieh, et al.
Publicado: (2017)

An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells
por: Zhang, Zhizhuo, et al.
Publicado: (2019)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
por: Furusato, B, et al.
Publicado: (2010)

Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status
por: Luedeke, Manuel, et al.
Publicado: (2016)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

Targeting PTEN-defined breast cancers with a one-two punch
por: Maggi, Leonard B, et al.
Publicado: (2015)

PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells
por: Chatterjee, Payel, et al.
Publicado: (2013)

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
por: Gumuskaya, Berrak, et al.
Publicado: (2013)

Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN
por: Shao, Longjiang, et al.
Publicado: (2018)

Sequence-function correlations and dynamics of ERG isoforms. ERG8 is the black sheep of the family
por: Hoesel, Bastian, et al.
Publicado: (2015)

Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia
por: Potuckova, Eliska, et al.
Publicado: (2016)

Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients
por: Abdel-Hady, Ahmed, et al.
Publicado: (2017)

A case of pediatric ALL with t(16;21)(p11.2;q22) and FUS-ERG rearrangement
por: Coccé, Mariela C., et al.
Publicado: (2015)

Acute basophilic leukemia associated with the t(16;21)(p11;q22)/FUS‐ERG fusion gene
por: Toda, Yusuke, et al.
Publicado: (2017)

Electrophysiological characterization of the hERG R56Q LQTS variant and targeted rescue by the activator RPR260243
por: Kemp, Jacob M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0l2kml63ui4i2l81ful2ud0h6q